EC-102NCT07087353
Efficacy of Remote Monitoring in Patients Treated for Moderate to Severe Major Depressive Episodes
At risk: Primary completion moved 2 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 6 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 6 words
- Primary completion pushed from Apr 1, 2027 to Jun 1, 2027
- Secondary endpoints: details revised at 1 of 3 entries
- Minor Study title expanded, about 1 wordv6
- Minor Study sites: 1 to 6v5
Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 5 more changesShow less
- Study sites: 0 to 1
- Primary completion date: Mar 1, 2027 to Apr 1, 2027
- Study completion date: Nov 1, 2027 to Dec 1, 2027
- Start date changed from estimate of Oct 1, 2025 to Oct 31, 2025
- Secondary endpoints: 2 to 3
- Minor Secondary endpoints: details revised at 1 of 2 entries
- Study title shortened, about 8 words
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Response rate over a 6-month period.
Timeframe: Month 6
Secondary (3)
Safety and absence of defects in Edra PRO over a 6-month period
Impact of Edra PRO versus usual care on patients' quality of life
Medico-economics impact of Edra PRO versus usual care
Arms and interventions
InterventionExperimental
Edra PRO
ControlNo intervention
Standard care
Devices: Edra PRO
Sites
6 sites in 1 country